PDL BioPharma Inc (PDLI):企業の財務・戦略的SWOT分析

◆英語タイトル:PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1330
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PDL BioPharma Inc (PDLI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc Key Recent Developments

Mar 11,2020: PDL BioPharma reports 2019 fourth quarter and full year financial results and announces plan to dissolve the company by year-end 2020
Mar 09,2020: PDL BioPharma announces appointment of Edward A. Imbrogno as vice president and chief financial officer
Feb 28,2020: PDL BioPharma Enters into cooperation agreement with Engine Capital
Dec 23,2019: PDL BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
PDL BioPharma Inc – Key Facts
PDL BioPharma Inc – Key Employees
PDL BioPharma Inc – Key Employee Biographies
PDL BioPharma Inc – Major Products and Services
PDL BioPharma Inc – History
PDL BioPharma Inc – Company Statement
PDL BioPharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PDL BioPharma Inc – Business Description
Business Segment: Income Generating Assets
Overview
Performance
Business Segment: Medical Devices
Overview
Performance
Business Segment: Pharmaceutical
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
PDL BioPharma Inc – Corporate Strategy
PDL BioPharma Inc – SWOT Analysis
SWOT Analysis – Overview
PDL BioPharma Inc – Strengths
PDL BioPharma Inc – Weaknesses
PDL BioPharma Inc – Opportunities
PDL BioPharma Inc – Threats
PDL BioPharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PDL BioPharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 11, 2020: PDL BioPharma reports 2019 fourth quarter and full year financial results and announces plan to dissolve the company by year-end 2020
Mar 09, 2020: PDL BioPharma announces appointment of Edward A. Imbrogno as vice president and chief financial officer
Feb 28, 2020: PDL BioPharma Enters into cooperation agreement with Engine Capital
Dec 23, 2019: PDL BioPharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Dec 09, 2019: PDL BioPharma announces completion of strategic review process
Nov 06, 2019: PDL BioPharma reports 2019 third quarter financial results
Sep 11, 2019: PDL BioPharma announces favorable decision in Wellstat Diagnostics litigation
Aug 07, 2019: PDL BioPharma reports 2019 second quarter financial results
Jun 25, 2019: PDL BioPharma announces departure of CFO
Jun 24, 2019: Natasha A. Hernday elected to PDL BioPharma’s board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
PDL BioPharma Inc, Key Facts
PDL BioPharma Inc, Key Employees
PDL BioPharma Inc, Key Employee Biographies
PDL BioPharma Inc, History
PDL BioPharma Inc, Subsidiaries
PDL BioPharma Inc, Key Competitors
PDL BioPharma Inc, Ratios based on current share price
PDL BioPharma Inc, Annual Ratios
PDL BioPharma Inc, Annual Ratios (Cont...1)
PDL BioPharma Inc, Annual Ratios (Cont...2)
PDL BioPharma Inc, Interim Ratios
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
PDL BioPharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
PDL BioPharma Inc, Performance Chart (2015 - 2019)
PDL BioPharma Inc, Ratio Charts
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[PDL BioPharma Inc (PDLI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kansas City Power & Light Co:企業の発電所・SWOT分析2018
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Enbridge Inc (ENB)-エネルギー分野:企業M&A・提携分析
    Summary Enbridge Inc. (Enbridge) is an integrated energy company. It carries out natural gas gathering, processing, transmission and distribution; transportation of crude oil; and marketing of petroleum products. The company also involved in power generation and transmission and has interests in ren …
  • TC Pipelines LP (TCP):企業の財務・戦略的SWOT分析
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • GlaxoSmithKline Plc (GSK)-医療機器分野:企業M&A・提携分析
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respira …
  • Premier Oil plc:企業の戦略・SWOT・財務分析
    Premier Oil plc - Strategy, SWOT and Corporate Finance Report Summary Premier Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Gramercy Property Trust:企業のM&A・事業提携・投資動向
    Gramercy Property Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gramercy Property Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Imperial d.d.:企業の戦略・SWOT・財務分析
    Imperial d.d. - Strategy, SWOT and Corporate Finance Report Summary Imperial d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PEN, Inc. (PENC):企業の財務・戦略的SWOT分析
    PEN, Inc. (PENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Penn Virginia Corp (PVAC):企業の財務・戦略的SWOT分析
    Penn Virginia Corp (PVAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cambrex Corp (CBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • WInco Foods LLC:企業の戦略・SWOT・財務情報
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Medigen Biotechnology Corp (3176)-製薬・医療分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Venture Corporation Limited:企業の戦略・SWOT・財務情報
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Delaware Municipal Electric Corporation, Inc.:企業の戦略的SWOT分析
    Delaware Municipal Electric Corporation, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆